People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Altea Therapeutics Corp | — | Biotechnology | Seed | $3.7M | $30.4M | 2010 |
Frank Tagliaferri at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frank Tagliaferri on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Anthony Evnin | 1 | 6 |
| Jesse I. Treu | 1 | 5 |
| Jesse Treu | 1 | 4 |
| Anthony B. Evnin | 1 | 4 |
| Alan Smith | 1 | 4 |
| Ruth Devenyns | 1 | 2 |
| William R. Good | 1 | 2 |
| Steven Damon | 1 | 2 |
| Harold Shlevin | 1 | 2 |
| Michael Hatch | 1 | 2 |
| Eric Tomlinson | 1 | 1 |
| William Good | 1 | 1 |
| Paul Tierney | 1 | 1 |
| Angela Walsh | 1 | 1 |
| Deborah Eppstein | 1 | 1 |
| Frank E. Tagliaferri | 1 | 1 |
| Paul E. Tierney | 1 | 1 |
| Steven P. Damon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.